Showing results (1-10 of 103) with videos related to
Sort By:
Pageof 11
The New Zealand Medical Journal|April 13, 2023
Amoebic colitis masquerading as inflammatory bowel disease for a decadeSailish Honap, Simon AndersonAlimentary Pharmacology & Therapeutics|August 21, 2023
Review article: Externally derived control arms-An opportunity for clinical trials in inflammatory bowel disease?Sailish Honap, Laurent Peyrin-BirouletGastroenterology & Hepatology|February 26, 2024
Are All Janus Kinase Inhibitors for Inflammatory Bowel Disease the Same?Sailish Honap, Silvio Danese, Laurent Peyrin-BirouletInflammatory Bowel Diseases|June 11, 2024
Target Trial Emulation: Improving the Quality of Observational Studies in Inflammatory Bowel Disease Using the Principles of Randomized TrialsSailish Honap, Silvio Danese, Laurent Peyrin-BirouletJournal of Crohn'S & Colitis|October 30, 2024
Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced TherapiesBénédicte Caron, Sailish Honap, Laurent Peyrin-BirouletEuropean Journal of Gastroenterology & Hepatology|September 19, 2023
JAK inhibitors for the treatment of inflammatory bowel disease: results of an international survey of perceptions, attitudes, and clinical practiceSailish Honap, Peter M Irving, Mark A SamaanLancet (London, England)|August 12, 2023
Ulcerative colitisCatherine Le Berre, Sailish Honap, Laurent Peyrin-BirouletNature Reviews. Drug Discovery|May 22, 2024
Navigating the complexities of drug development for inflammatory bowel diseaseSailish Honap, Vipul Jairath, Silvio Danese, et al.Expert Opinion on Drug Safety|August 23, 2023
An update on the safety of long-term vedolizumab use in inflammatory bowel diseaseSailish Honap, Patrick Netter, Silvio Danese, et al.Clinical and Experimental Gastroenterology|October 6, 2025
Optimising Monoclonal Antibody Drug Development for Inflammatory Bowel DiseaseMichael Colwill, Sailish Honap, Silvio Danese, et al.Pageof 11